Chimeric Therapeutics Ltd (CHM) — Financial Flexibility Index
Chimeric Therapeutics Ltd (CHM) has a Financial Flexibility Index of -0.43x as of December 2025. Free cash flow of AU$-3.84 Million (operating CF AU$-3.84 Million minus capex AU$5.00) represents 0% of total liabilities (AU$8.96 Million). Check tangible equity quality of Chimeric Therapeutics Ltd to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Chimeric Therapeutics Ltd Financial Flexibility Index (2020–2025)
Historical Financial Flexibility Index trend for Chimeric Therapeutics Ltd across 6 annual periods. For the full cash flow conversion analysis, see Chimeric Therapeutics Ltd cash conversion from operations.
Annual Financial Flexibility Index for Chimeric Therapeutics Ltd (2020–2025)
Year-by-year free cash flow to debt coverage for Chimeric Therapeutics Ltd. Explore CHM operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (AUD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.37x | AU$-7.28 Million | AU$-7.28 Million | AU$19.60 Million | ▼ -47103.4% |
| 2024 | 0.00x | AU$10.11K | AU$-7.54 Million | AU$12.80 Million | ▲ +100.1% |
| 2023 | -0.97x | AU$-16.20 Million | AU$-16.32 Million | AU$16.71 Million | ▲ +29.5% |
| 2022 | -1.38x | AU$-12.62 Million | AU$-13.15 Million | AU$9.17 Million | ▼ -342.4% |
| 2021 | -0.31x | AU$-3.54 Million | AU$-8.84 Million | AU$11.37 Million | ▼ -12.1% |
| 2020 | -0.28x | AU$-17.75K | AU$-34.01K | AU$64.01K | — |